Outlook Therapeutics, Inc. Purchase Agreements
12 Contracts & Agreements
- Form of Securities Purchase Agreement, dated as of December 23, 2022, by and between the Company and the Purchasers (Filed With SEC on December 23, 2022)
- Securities Purchase Agreement, dated as of December 22, 2022, by and between the Company and Streeterville Capital, LLC (Filed With SEC on December 22, 2022)
- Securities Purchase Agreement, dated February 9, 2021, by and between the Company and GMS Ventures and Investments (Filed With SEC on February 11, 2021)
- Securities Purchase Agreement, dated January 28, 2021, by and between the Company and Syntone Ventures LLC (Filed With SEC on February 2, 2021)
- Securities Purchase Agreement, dated June 22, 2020, by and between the Company and Syntone Ventures LLC (Filed With SEC on June 23, 2020)
- Form of Securities Purchase Agreement, dated June 22, 2020, by and among the Company and the purchasers named therein (Filed With SEC on June 23, 2020)
- Securities Purchase Agreement by and between the Company and GMS Ventures and Investments dated February 24, 2020 (Filed With SEC on February 24, 2020)
- Form of Securities Purchase Agreement, dated February 24, 2020, by and among the Company and the purchasers named therein (Filed With SEC on February 24, 2020)
- Purchase Agreement by and between Oncobiologics, Inc. and BioLexis Pte. Ltd., dated November 5, 2018 (Filed With SEC on November 9, 2018)
- Purchase Agreement by and between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited, dated May 11, 2018 (Filed With SEC on May 15, 2018)
- Purchase Agreement by and between Oncobiologics, Inc. and the Investor named therein, dated September 7, 2017 (Filed With SEC on September 11, 2017)
- PURCHASE AGREEMENT (Filed With SEC on March 9, 2017)
